Long-term trends in cancer mortality for Indigenous Australians in the Northern Territory
Authors: John R Condon, Joan Cunningham, Tony Barnes and Bruce K Armstrong
Published online: 2 January 2006
Re: “Long-term trends in cancer mortality for Indigenous Australians in the Northern Territory”, by John R Condon, Tony Barnes, Joan Cunningham and Bruce K Armstrong, in the 17 May 2004 issue of the Journal (Med J Aust 2004; 180: 504-507). Box 1 on page 505 of this article inadvertently included some incorrect data. The corrected table is shown with the changes in bold text.
The html and pdf versions of this article were corrected on 1 December 2005.
In summary:
for oesophageal cancer, the corrected mortality rate ratios (NT Indigenous to total Australian) are higher than the published results in all age categories;
for stomach cancer, the corrected rate ratio for the 0–64 age group is lower than the published figure, and the all-ages result is now reported because the difference between the younger and older age groups is no longer statistically significant (P = 0.06);
for cancer of the liver and gallbladder, the corrected rate ratios are lower in the 0–64 years and all-ages groups; and
there are also very slight changes for breast and lung cancers.
These changes do not alter the inferences that might reasonably be drawn from the results in the table, or the overall findings of the study and their interpretation.
Cancer mortality rate ratios* (NT Indigenous population compared with the total Australian population), by age group, 1991–2000
Site/type of cancer |
0–64 years |
65 years and over |
All ages† |
Interaction P value† |
|||||||||||
Oropharynx |
8.0 (5.5, 11.6) |
2.0 (0.8, 4.8) |
— |
< 0.01 |
|||||||||||
Oesophagus |
2.9 (1.5, 5.6) |
1.2 (0.5, 2.9) |
1.9 (1.1, 3.2) |
0.11 |
|||||||||||
Stomach |
1.4 (0.6, 3.0) |
0.2 (0.0, 1.2) |
0.7 (0.3, 1.4) |
0.06 |
|||||||||||
Colon and rectum |
0.9 (0.5, 1.4) |
0.2 (0.1, 0.6) |
— |
0.01 |
|||||||||||
Liver and gallbladder |
5.5 (3.6, 8.6) |
5.8 (3.9, 8.6) |
5.7 (4.2, 7.6) |
0.88 |
|||||||||||
Pancreas |
4.1 (2.7, 6.3) |
1.1 (0.5, 2.2) |
— |
< 0.001 |
|||||||||||
Lung |
3.6 (2.9, 4.5) |
1.4 (1.0, 1.9) |
— |
< 0.001 |
|||||||||||
Melanoma |
0.0 |
0.0 |
0.0 |
na |
|||||||||||
Breast |
0.8 (0.5, 1.3) |
0.9 (0.4, 1.8) |
0.8 (0.6, 1.3) |
0.86 |
|||||||||||
Uterus‡ |
3.4 (1.1, 10.7) |
2.5 (0.8, 7.6) |
2.9 (1.3, 6.4) |
0.68 |
|||||||||||
Cervix |
8.0 (5.2, 12.4) |
10.1 (5.4, 19.1) |
8.6 (6.0, 12.3) |
0.56 |
|||||||||||
Ovary |
1.0 (0.4, 2.6) |
1.3 (0.5, 3.5) |
1.1 (0.6, 2.2) |
0.67 |
|||||||||||
Prostate |
0.9 (0.2, 3.6) |
0.3 (0.1, 0.8) |
0.4 (0.2, 0.8) |
0.23 |
|||||||||||
Bladder |
1.5 (0.4, 6.1) |
0.5 (0.1, 1.9) |
0.7 (0.3, 1.9) |
0.24 |
|||||||||||
Kidney |
0.3 (0.0, 2.2) |
0.0 |
0.1 (0.0, 1.0) |
1.00 |
|||||||||||
Thyroid |
12.9 (4.8, 34.7) |
6.1 (1.5, 24.7) |
9.4 (4.2, 21.1) |
0.40 |
|||||||||||
Unknown primary |
3.2 (2.1, 4.7) |
1.7 (1.0, 2.6) |
— |
0.04 |
|||||||||||
Non-Hodgkin’s lymphoma |
1.1 (0.5, 2.2) |
0.7 (0.2, 1.7) |
0.9 (0.5, 1.6) |
0.40 |
|||||||||||
Leukaemia |
1.5 (0.9, 2.5) |
0.8 (0.3, 2.0) |
1.2 (0.8, 1.9) |
0.25 |
|||||||||||
* Mortality rate ratio estimated by negative binomial regression. † Mortality rate ratios are reported separately for age groups 0–64 and 65 years and over; the rate ratio for all ages combined is reported only where the P value of an interaction term testing for difference in mortality rate between younger and older age groups was > 0.05. |
|||||||||||||||
Watchful Waiting Compared With Immediate Antibiotics for Urban Aboriginal and Torres Strait Islander Children With Uncomplicated Acute Otitis Media (WATCH): A Non-Inferiority Randomised Controlled Trial
Jennifer S. Reath, Hasantha Gunasekera, Sanja Lujic, Amanda J. Leach, Letitia Campbell, Robyn Walsh, Tim Usherwood, Geoffrey K. Spurling, Claudette A. Tyson, Deborah A. Askew, Kelvin Kong, Chelsea J. Watego, Peter Morris, Wendy Hu, Penelope A. Abbott
Beds Still Burning: Suicide Should Not Be in the Vocabulary of Children
Rudi Louis Taylor-Bragge
Weight Loss Medication Marketing and First Nations People: Disease Awareness or Corporate Profit?
Troy Walker, Simone Sherriff, Jennifer Browne
Beyond Mammography: Sovereignty and Relational Breast Care With Aboriginal and Torres Strait Islander Women
Devaleena Das, Jessica Gildersleeve, Amy Thomson, Aunty Gracelyn Smallwood, Lorelle Holland
Responding to the Revised First Nations Health and Cultural Safety Accreditation Standards in Australian Primary Medical Education: Institutional Principles and Qualities for Meaningful Progress
Sophie Pitt, Ashlee Williams-Barnes, Ryan Dashwood, Keira Edwards, Paul Saunders
Drivers of Vaccine Uptake for Aboriginal and Torres Strait Islander Children to Inform Tailored Strategies: A Qualitative Study Exploring Health Service Provider Perspective
Bianca F. Middleton, Kristy Crooks, Kylie Taylor, Elizabeth Harwood, Katrina K. Clark, Caitlin Kent, Kelly McCrory, Marita Hefler, Jessica Kaufman, David N. Durrheim, Margie H. Danchin